Various forms of diffuse parenchymal lung disease have been proposed as potential consequences of severe COVID‑19. We describe the clinical, radiological and histological findings of patients with COVID‑19-associated acute respiratory distress syndrome who later developed severe organising pneumonia including longitudinal follow-up. Our findings may have important implications for the therapeutic modalities in the late-phase of severe COVID‑19 and might partially explain why a subgroup of COVID‑19 patients benefits from systemic corticosteroids.
- Vadász, I.
- Husain-Syed, F.
- Dorfmüller, P.
- Roller, F. C.
- Tello, K.
- Hecker, M.
- Morty, R. E.
- Gattenlöhner, S.
- Walmrath, H. D.
- Grimminger, F.
- Herold, S.
- Seeger, W.
Keywords
- Ards
- bronchoscopy
- critical care
- rare lung diseases
- viral infection
